The present community-based study assessed the prevalence of chronic kidney disease (CKD)/chronic kidney disease of unknown origin (CKDu) as well as anemia in some intense agricultural zones under ...

Patients’ smoking behaviors may be associated with elevated risks for chronic kidney disease, but more data are needed, ...

Collaboration will support access of an alternative treatment to improve the lives of people impacted by anemia caused by ...

This model exhibits ... New Method Predicts Worsening of Chronic Kidney Disease Sep. 12, 2024 — Researchers have developed a new method that could be a significant step in the treatment of ...

In patients with cystic renal diseases (in whom mild or no anemia with elevated erythropoietin ... even in advanced chronic kidney disease; cysts derived from proximal tubules, but not those ...

Akebia has since engaged with the FDA on potentially expanding vadadustat treatment to this patient population and has received feedback on a protocol submitted for a Phase 3 cardiovascular outcome ...

The global anemia treatment market was valued at USD 10.0 billion in 2022 and is expected to grow to USD 14.9 billion by 2028 ...

Therapeutics announced multiple positive business updates. As of January, Vafseo tablets are available in the U.S. for adult ...

Obesity is an important health issue for patients with chronic kidney disease, speeding its progression, contributing to ...

Valleant’s recently released guide aims to help individuals better understand anemia, explore treatment options, and offer nutritional and lifestyle advice to support the management of ...

Disc Medicine, Inc. (NASDAQ:IRON), a biotechnology company focused on developing treatments for rare blood disorders, has ...